Diploid selected in Genomics England’s annotation assessment
In an effort led by the NHS, the United Kingdom is about to sequence 100,000 patients by the end of 2017. Genomics England, the company leading this landmark project, therefore organised an annotation assessment earlier this year. Today, the results have been announced and Diploid is among the winners of this worldwide competition.
Read the full press release on our press page